Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA PANACEA BIOTECH ALEMBIC PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x 38.8 0.8 5,009.1% View Chart
P/BV x 2.3 1.0 232.2% View Chart
Dividend Yield % 1.6 0.0 -  

Financials

 ALEMBIC PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-22
PANACEA BIOTECH
Mar-22
ALEMBIC PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,090454 240.2%   
Low Rs672148 454.1%   
Sales per share (Unadj.) Rs269.9108.0 250.0%  
Earnings per share (Unadj.) Rs26.2176.0 14.9%  
Cash flow per share (Unadj.) Rs40.8183.1 22.3%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs266.5138.6 192.3%  
Shares outstanding (eoy) m196.5661.25 320.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.32.8 117.1%   
Avg P/E ratio x33.61.7 1,964.5%  
P/CF ratio (eoy) x21.61.6 1,313.5%  
Price / Book Value ratio x3.32.2 152.3%  
Dividend payout %38.10-   
Avg Mkt Cap Rs m173,17218,427 939.8%   
No. of employees `000NANA-   
Total wages/salary Rs m11,3301,829 619.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,0586,612 802.4%  
Other income Rs m505110 460.3%   
Total revenues Rs m53,5636,722 796.8%   
Gross profit Rs m8,74116,623 52.6%  
Depreciation Rs m2,868437 656.8%   
Interest Rs m1771,808 9.8%   
Profit before tax Rs m6,20114,488 42.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0453,709 28.2%   
Profit after tax Rs m5,15710,779 47.8%  
Gross profit margin %16.5251.4 6.6%  
Effective tax rate %16.825.6 65.8%   
Net profit margin %9.7163.0 6.0%  
BALANCE SHEET DATA
Current assets Rs m29,74810,406 285.9%   
Current liabilities Rs m18,3068,028 228.0%   
Net working cap to sales %21.636.0 60.0%  
Current ratio x1.61.3 125.4%  
Inventory Days Days1161 17.3%  
Debtors Days Days673 7.6%  
Net fixed assets Rs m42,5547,118 597.8%   
Share capital Rs m39361 641.8%   
"Free" reserves Rs m51,9828,427 616.9%   
Net worth Rs m52,3758,488 617.1%   
Long term debt Rs m0341 0.0%   
Total assets Rs m72,30217,523 412.6%  
Interest coverage x36.09.0 399.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.4 194.5%   
Return on assets %7.471.8 10.3%  
Return on equity %9.8127.0 7.8%  
Return on capital %12.2184.6 6.6%  
Exports to sales %43.818.2 240.4%   
Imports to sales %12.722.4 56.5%   
Exports (fob) Rs m23,2511,205 1,929.1%   
Imports (cif) Rs m6,7281,484 453.2%   
Fx inflow Rs m23,2511,236 1,881.7%   
Fx outflow Rs m6,7281,735 387.8%   
Net fx Rs m16,523-499 -3,308.9%   
CASH FLOW
From Operations Rs m5,524-1,084 -509.4%  
From Investments Rs m-3,72012,826 -29.0%  
From Financial Activity Rs m-2,174-11,759 18.5%  
Net Cashflow Rs m-370-17 2,137.7%  

Share Holding

Indian Promoters % 69.1 73.6 93.9%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 18.1 0.0 -  
FIIs % 5.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 26.4 115.1%  
Shareholders   101,457 49,896 203.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    LUPIN    


More on ALEMBIC PHARMA vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Panacea Biotech Share Price Performance

Period ALEMBIC PHARMA Panacea Biotech S&P BSE HEALTHCARE
1-Day -0.28% -3.88% -0.46%
1-Month -6.39% 2.10% 0.65%
1-Year -25.73% -53.21% -13.70%
3-Year CAGR 4.20% -2.71% 20.93%
5-Year CAGR 4.71% -8.78% 10.98%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 38.1%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

5 Reasons Why Sensex Plunged 1,021 Points Today(Closing)

After opening the day on a negative note, Indian share markets extended losses as the session progressed and ended deep in the red.